Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

Pharmaceutical companies in China report importing drugs with tariff exemptions, indicating possible flexibility from Chinese ...

In the high-stakes world of pharmaceutical manufcturing, where regulatory compliance meets razor-thin margins and patient safety, one industry leader is redefining what Lean transformation means in ...

A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.

Pharmaceutical companies in China are reportedly importing some drugs without tariffs, a sign of potential flexibility amid ...

Industries that range from pharmaceuticals to tech, and even fashion, have signaled they could build more capacity in the U.S ...

SHANGHAI (Reuters) -The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...